Search Results

- 27, 2025 | American Physiology Summit 2025 NEW April 25 - 30, 2025 | AACR Annual Meeting 2025 NEW May 12 - 15, 2025 | PEGS 2025 NEW May 20 - 22, 2025 | SLAS Europe 2025 NEW June 16 - 19, 2025 | BIO International

The takeaway:  what looks like pharmacology failure may be a systems problem .

The recognition that GPCRs may physically interact with each other has led to the hypothesis that their distinct cell compartments along the plasma membrane where confined increases in second messengers may

receptors (SSTs) are class A GPCRs abundantly expressed in pituitary tumors where they represent the main Moreover, whether octreotide or pasireotide may play modulatory effects and whether FLNA may participate

Studies of GPR21 knock-out mice indicated that GPR21 may be involved in promoting macrophage migration

Behind Every Probe Is a Partnership While the final product may arrive neatly packaged, the journey behind

Food and Drug Administration (FDA) that the study may proceed.

Despite a better understanding of the disease, the current mainstay of treatment cannot modify pathogenesis provide insights into some novel strategies, including allosterism and the targeting of oligomers, which may

(May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023).

upon activation than previously solved class A GPCR-Gi complex structures is observed in CX3CR1, which may

PLC activities self-regulate the expression of PLC isozymes with the suggestion that PLC activities may

Ligands eliciting biased signalling may constitute better drugs with higher efficacy and fewer adverse

Despite a better understanding of the disease, the current mainstay of treatment cannot modify pathogenesis provide insights into some novel strategies, including allosterism and the targeting of oligomers, which may

August 2022 "Bone remodeling is precisely regulated mainly by osteoblasts and osteoclasts. Considering that synaptamide is the endogenous metabolite of DHA, we hypothesized that DHA may inhibit

(May 22 - 26, 2023) 2nd ERNEST Training School. (February 20 - March 3, 2023). GEM2023. (May 3-7, 2023). The Illuminating the Understudied Druggable Proteome Conference.

We discuss how such events may be distinct depending on where the GPCRs and their associated signaling

Although blockade of GPR84 may potentially prove effective also in diseases associated with inflammation

May 2022 "Seoul, South Korea, 28 April 2022 – GPCR therapeutics, Inc., a venture-backed clinical stage

This approach reveals: Hidden target overlap New therapeutic hypotheses “Off-target” effects that may They are mainstream pharmacology.

We also discuss how advancing technologies to discover nanobodies with tailored specificities may expand

This mechanism may explain the inability of GPCRs to scramble lipids at the plasma membrane."

The identification of unified innate threat pathways may provide insights into developing therapeutic

Curves that “look fine” may hide non-equilibrated systems. The fix?

Slopes <1  may reveal allosteric modulation , where the antagonist binds at a secondary site.

A project to develop a perfect drug, or a drug that is as safe and effective as possible, may never begin

of the localization and function of PAR2 was significantly delayed after stimulation by GB83, which may

Curr Chem Genomics. 2009 May 28;3:22-32. doi: 10.2174/1875397300903010022.

cortex, hippocampus, and especially the striatum, demonstrating that the balance between TrkB and 5-HT2A may

Our observations with these prominent commonalities may provide new insights into the phenotype and characteristics

perception, and thought, and have the activation of serotonin (5-HT) 2A receptors (5-HT2A Rs) as a main studies, both linked to the specific assay mechanism and linked to its specific execution, as these may